Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

Meanwhile, federal funding cuts and dismantled CDC HIV prevention programs could make it hard to reach the people most at risk—particularly low-income communities, women, and people of color.

The Food and Drug Administration on Wednesday approved a powerful new drug that provides almost complete protection against HIV infections. The twice-yearly injection, known as lenacapavir, offers ...

HIV advocates hope lenacapavir, a long-acting, injectable HIV-prevention drug, could be a game changer in the fight against the virus. Nardus Engelbrecht / AP file Sept. 12, 2024, 9:43 AM EDT ...

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

By Dennis Thompson HealthDay ReporterTUESDAY, May 13, 2025 (HealthDay News) — Drugs that battle HIV and hepatitis B might be able to help people avoid Alzheimer’s disease, a new study says.